lasofoxifene tartrate
Phase 3- Indications
- ER-positive/HER2-negative/ESR1-mutated breast cancer
Company intelligence / Profile preview
Azure Biotech is a global leader in the research, development, production, and sales of diagnostic reagents and POCT analyzers. The company’s portfolio includes over one hundred products across nine series for clinical diagnostics, with significant market share in drug detection in Europe. Their R&D team exceeds one hundred employees and they maintain collaborations with leading domestic and international research institutions.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Azure Biotech Inc..